Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples

被引:7
|
作者
Angeloni, D [1 ]
Danilkovitch-Miagkova, A
Ivanov, SV
Breathnach, R
Johnson, BE
Leonard, EJ
Lerman, MI
机构
[1] NCI, Frederick Canc Res & Dev Ctr, Immunobiol Lab, Frederick, MD 21702 USA
[2] Sci Applicat Int Corp, Frederick Canc Res & Dev Ctr, Intramural Res Support Program, Frederick, MD 21702 USA
[3] Inst Biol, Nantes, France
[4] NCI, USN, Med Branch, NIH, Bethesda, MD 20892 USA
来源
GENES CHROMOSOMES & CANCER | 2000年 / 29卷 / 02期
关键词
D O I
10.1002/1098-2264(2000)9999:9999<::AID-GCC1015>3.0.CO;2-N
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The human RON gene (MSTIR) maps to 3p21.3, a region frequently altered in lung cancer and other malignancies. It encodes a receptor tyrosine kinase (RTK) closely related to MET, whose mutations are associated with neoplasia. We investigated whether RON might be involved in the development or progression of lung cancer. We first determined the exon-intron structure of the gene by direct sequencing of RON cosmid DNA and PCR products containing intronic sequences, and then developed primers suitable for mutation analysis by the single-strand conformation polymorphism (SSCP) method. Twenty coding exons were characterized, ail but the first one small (average size: 170 bp), a feature shared with other RTK genes. We performed SSCP analysis of RON in small and non-small cell lung cancer samples, upon detection of its expression in a sample of lung cancer cell lines. A mutation (T915C: L296P) was found in an adenocarcinoma specimen. Several single nucleotide polymorphisms were also found. The panel of intron-anchored primers developed in this work will be useful for mutation analysis of the RON gene in different types of human tumors. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:147 / 156
页数:10
相关论文
共 50 条
  • [41] The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells
    M N Thobe
    D Gurusamy
    P Pathrose
    S E Waltz
    Oncogene, 2010, 29 : 214 - 226
  • [42] Ron Receptor Tyrosine Kinase Activation Confers Resistance to Tamoxifen in Breast Cancer Cell Lines
    McClaine, Rebecca J.
    Marshall, Aaron M.
    Wagh, Purnima K.
    Waltz, Susan E.
    NEOPLASIA, 2010, 12 (08): : 650 - 658
  • [43] Receptor Tyrosine Kinase Profiling Identifies RON Tyrosine Kinase in Hodgkin and Non-Hodgkin Lymphoma
    Coffing, B. N.
    Mankey, C. C.
    Wey, E. A.
    Mongia, S.
    McNeil, C.
    Thomas, D. G.
    Keyoumarsi, F.
    Elenitoba-Johnson, K. S. J.
    Lim, M. S.
    MODERN PATHOLOGY, 2010, 23 : 291A - 291A
  • [44] The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells
    Thobe, M. N.
    Gurusamy, D.
    Pathrose, P.
    Waltz, S. E.
    ONCOGENE, 2010, 29 (02) : 214 - 226
  • [45] Analysis of RON receptor tyrosine kinase and its splicing variant in malignant and non-malignant human colonic mucosa
    Okino, T
    Egami, H
    Ohmachi, H
    Takai, E
    Tamori, Y
    Nakagawa, K
    Nakano, S
    Akagi, J
    Sakamoto, O
    Suda, T
    Ogawa, M
    BIOLOGICAL RESPONSE TO PLANNED AND UNPLANNED INJURIES: CELLULAR, MOLECULAR AND GENETIC ASPECTS, 2003, 1255 : 271 - 274
  • [46] Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery
    Zarei, Omid
    Benvenuti, Silvia
    Ustun-Alkan, Fulya
    Hamzeh-Mivehroud, Maryam
    Dastmalchi, Siavoush
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (12) : 2429 - 2446
  • [47] MODULATION OF MEGAKARYOCYTOPOIESIS BY HUMAN MACROPHAGE STIMULATING PROTEIN, A NOVEL LIGAND FOR THE TYROSINE KINASE RECEPTOR RON
    BANU, N
    LONDON, R
    DENG, B
    LEVINE, J
    GALLO, K
    GODOWSKI, P
    AVRAHAM, H
    BLOOD, 1994, 84 (10) : A269 - A269
  • [48] Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines
    Chen, YQ
    Zhou, YQ
    Angeloni, D
    Kurtz, AL
    Qiang, XZ
    Wang, MH
    EXPERIMENTAL CELL RESEARCH, 2000, 261 (01) : 229 - 238
  • [49] Colorectal cancer progression is marked by overexpression and activation of splicing variants of the RON receptor tyrosine kinase
    Spidel, Celee
    Zhou, Yong-Qing
    Wang, Ming-Hai
    CANCER RESEARCH, 2006, 66 (08)
  • [50] ShRNA silencing of the RON receptor tyrosine kinase results in apoptosis and necrosis of pancreatic cancer xenografts
    Logan-Collins, J. M.
    Stuart, W.
    Waltz, S.
    Lowy, A. M.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 36 - 36